Inventor

SANDNER PETER

DE11 patents

⚠️ This page may combine multiple inventors who share the name “SANDNER PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

Bayer Pharma AG

4 patents

US10918639B2Feb 16, 2021

Combination containing SGC stimulators and mineralocorticoid receptor antagonists

Bayer Pharma AG3 citations71

US11684621B2Jun 27, 2023

Combination containing sGC stimulators and mineralocorticoid receptor antagonists

Bayer Pharma AG0 citations61

US11331308B2May 17, 2022

Combination containing sGC activators and mineralocorticoid receptor antagonists

Bayer Pharma AG1 citations61

US10265314B2Apr 23, 2019

SGC stimulators in combination with additional treatment for the therapy of cystic fibrosis

Bayer Pharma AG0 citations51

BAYER AG

3 patents

US12195448B2Jan 14, 2025

Substituted pyrazolo piperidine carboxylic acids

BAYER AG4 citations69

US12595247B2Apr 7, 2026

Substituted pyrazolo piperidine carboxylic acids

BAYER AG0 citations57

US11439628B2Sep 13, 2022

Use of non-steroidal mineralocorticoid receptor antagonists alone or in combination for the treatment of muscular or neuromuscular diseases

BAYER AG0 citations55

HIRTH DIETRICH CLAUDIA

1 patent

US10189856B2Jan 29, 2019

Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc)

HIRTH DIETRICH CLAUDIA4 citations67

KLAR JÜRGEN

1 patent

US9040566B2May 26, 2015

Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension

KLAR JÜRGEN2 citations57

ADVERIO PHARMA GMBH

1 patent

US11508483B2Nov 22, 2022

Method of identifying a subgroup of patients suffering from dcSSc which benefits from a treatment with sGC stimulators and sGC activators in a higher degree than a control group

ADVERIO PHARMA GMBH0 citations47

KLEIN MARTINA

1 patent

US8304406B2Nov 6, 2012

Compounds for treating pulmonary hypertension

KLEIN MARTINA2 citations38